About Singapore’s Annual Meeting On Biosimilars And Drug Delivery

Key Discussions on Biosimilars 2019
Current regulatory status of biosimilar medicines in the EU
Market access and regulatory developments
Sustainability of the biosimilar medicines sector
Advances and convergence of regulatory science
Regulatory requirements, scientific and operational challenges
Biosimilar Development and Manufacturing
Pharmacovigilance
Clinical Trials
Legal Considerations on Biosimilars
FDA-Approved biosimilar products
Prescribing biosimilar and generics drugs

For More Info visit event links:

Website of Singapore’s Annual Meeting On Biosimilars And Drug Delivery